Celadon Pharmaceuticals Plc announced last week that it has been approved to commence a unique non-cancer chronic pain clinical trial for up to 5,000...
Initial conclusions of the combined first and second cohorts of a US cannabidiol industry-sponsored liver safety study has indicated a good safety profile for...